Cite

MLA Citation

    Johannes Lutz et al.. “Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines.” Npj vaccines, vol. 2, 2017, pp. 1–9. http://access.bl.uk/ark:/81055/vdc_100084801975.0x000069
  
Back to record